about o2h kickstarter
o2h Discovery is a fully integrated Anglo-Indian CRO with a global client base. The o2h kickstarter competition has been developed to provide a boost to small molecule focused biotechnology companies which have usually raised some initial funding and need to supercharge their chemistry efforts to meet their next funding milestone. We at o2h Discovery are driven by innovations in medicinal chemistry drug discovery research that develops new drugs and therapies for various diseases, satisfying the unmet needs for healthy human life and well-being.
winners feedback from the first competition
More than 30 companies applied from across the globe, and here are the six companies who made it to the winners list.

Dr Neil Benson
CEO

Winning the o2h Kickstarter competition will significantly increase our chemistry resource and in turn accelerate delivery of our goals.

Jason Rutt
CEO

We are absolutely delighted to win an inaugural kickstarter award. It's fantastic that one of Britains top CROs is prepared to back companies like ours.

Chris Moody
Co-founder

the o2h kickstarter competition promises to be an excellent scheme allowing early-stage companies like ours to get access to synthetic chemistry.

Vid Stojevic
CEO & Co-founder

The kickstarter provides vital access to chemists with the skills and knowledge to deliver on the promise of our technology.

Dr Janette A Thomas
CEO

I am thrilled that Five Alarm Bio has been awarded the Kickstarter program. We will benefit from the extensive knowledge and enthusiasm of the o2h leadership and laboratory scientists.

Beth J Hoffman
President & CEO

The Kickstarter will enable us to thoroughly explore our nascent SAR and advance our lead program more rapidly.
benefits
team
A dedicated team of six FTE synthetic chemists of which two are experienced and four are trainees.
cost & duration
Six synthetic chemists at a fraction of the usual price for up to six months.

additional support
Receive 100 complimentary ADME points and save 20% on Biology FTE.
inventory
Access to a large inventory of chemicals and reagents for synthesis.
eligibility
The competition is for pre-seed stage small molecule focused biotech companies which have secured initial funding from recognized grant bodies or venture/angel investors, has exciting drug targets and ability to scale.
Know moreevaluation
The applications will be evaluated by the o2h Kickstarter committee and 3 winners will be announced soon. This is a time limited competition. If supportive to the global biotech ecosystem we will run this again.